← Evidence map

ReviewNeuroRx : the journal of the American Society for Experimental NeuroTherapeutics2004

Biomarkers and surrogate markers: an FDA perspective.

Russell KatzPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

136 papers cite itlatest 60 shown

2004
…
2007
2009
2010
2011
2013
2014
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 15717019